Accumulating studies indicate that activation of Toll-like receptors (TLRs) promotes the development of cancer by activating nuclear factor-κB (NF-κΒ) pathway and the transducer signal transducer and activator of transcription 3 (STAT3) in colon, gastric and liver cancers [55, 56]. The gene discussed is STAT3; the disease is cancer.